Synapsoft logo
AI Insights from Disclosures
Searching...
Boryung Corporation 003850
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Boryung Corporation's pharmaceutical business is advancing step by step toward sustainable growth with strengthening profitability as its top priority. To secure a stable cash-generating capability through strengthened profitability, the company has established key strategies based on fundamental innovations such as strengthening high-margin in-house product competitiveness and building a stable, chronic-disease-centered portfolio, and is striving to become a leading healthcare company.
Representative Director Kim Jeonggyun
Founded November 11, 1963
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-0012560
Business number 208-81-00281
Phone Number 02-708-8000
Fax Number 02-3673-0406
Company Address 136 Changgyeonggung-ro, Jongno-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant